Pharmacy Distribution Stocks in India

4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is guarded: positive earnings, positive 5–60% three-year EPS growth, and a positive P/E are required.

Revenue Scale & Growth Durability

Medplus Health Services Ltd has the highest Revenue among the 4 Pharmacy Distribution companies compared here, at ₹7,229 crore. Entero Healthcare Solutions Ltd is next at ₹6,592 crore. Entero Healthcare Solutions Ltd has the highest Revenue growth at 29.4%, so level and change sit with different companies. 4 of 4 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Medplus Health Services Ltd is the scale leader at ₹7,229 crore, 9.7% ahead of Entero Healthcare Solutions Ltd. Entero Healthcare Solutions Ltd's growth is 29.4% from a ₹6,592 crore base, with 14 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

Investor read: Medplus Health Services Ltd is the scale benchmark; Entero Healthcare Solutions Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Medplus Health Services Ltd's growth falls below Entero Healthcare Solutions Ltd's for two consecutive comparable reports while operating margin also compresses.

Operating Economics & Margin Trend

Medplus Health Services Ltd has the highest OPM among the 4 Pharmacy Distribution companies compared here, at 7%. Entero Healthcare Solutions Ltd is next at 4%. Sastasundar Ventures Ltd has the highest Margin change at +5.4 percentage points, so level and change sit with different companies. 4 of 4 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Medplus Health Services Ltd leads opm at 7%; Sastasundar Ventures Ltd leads margin change at +5.4 percentage points.

Investor read: Medplus Health Services Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Profit Scale & Acceleration

Medplus Health Services Ltd has the highest Net profit among the 4 Pharmacy Distribution companies compared here, at ₹211 crore. Entero Healthcare Solutions Ltd is next at ₹146 crore. Health X Platform Ltd has the highest Profit growth at 99.3%, so level and change sit with different companies. Its Net profit series carries 20 reported observations across the 20-quarter window.

What the numbers say: Medplus Health Services Ltd leads with ₹211 crore of TTM profit, 44.5% above Entero Healthcare Solutions Ltd. Health X Platform Ltd shows 99.3% growth from a ₹1 crore net cash profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

Investor read: Medplus Health Services Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Capacity Spending & Returns On It

No company in this Pharmacy Distribution comparison reports capital expenditure on a comparable basis, so there is nothing to rank here — 0 of 4 companies have a usable current reading. The section is shown rather than removed so an unavailable metric is not mistaken for one that was quietly left out. Filings were read through Jun 2026.

Withheld from this comparison: Entero Healthcare Solutions Ltd (ENTERO) — its two data sources disagree by up to 37% on reported income across 14 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.

Debt Load & Balance-Sheet Headroom

Sastasundar Ventures Ltd has the lowest Gross debt among the 4 Pharmacy Distribution companies compared here, at ₹5 crore. Health X Platform Ltd is next at ₹26 crore. Health X Platform Ltd has the lowest Net debt at ₹4 crore net cash, so level and change sit with different companies.

What the numbers say: Health X Platform Ltd has the clearest covered balance-sheet capacity with ₹4 crore net cash and gross debt of ₹26 crore. Absolute debt alone does not identify the strongest balance sheet because company scale differs; net debt and debt-to-equity carry more information.

Investor read: Prioritize net-cash capacity and leverage relative to operating scale, not the smallest absolute rupee debt.

This conclusion weakens if: Net debt rises faster than revenue and profit for two consecutive reported periods.

Return On Capital Employed

Medplus Health Services Ltd has the highest ROCE among the 4 Pharmacy Distribution companies compared here, at 12.6%. Entero Healthcare Solutions Ltd is next at 10.6%. Entero Healthcare Solutions Ltd has the highest ROCE change at +2 percentage points, so level and change sit with different companies. 4 of 4 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Medplus Health Services Ltd leads ROCE at 12.6%, 2 percentage points above Entero Healthcare Solutions Ltd. Entero Healthcare Solutions Ltd has the strongest latest improvement at +2 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

Investor read: Medplus Health Services Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

Valuation Against Growth & Quality

Medplus Health Services Ltd has the lowest Guarded PEG among the 4 Pharmacy Distribution companies compared here, at 1×. Sastasundar Ventures Ltd has the lowest P/E at 33.7×, so level and change sit with different companies. 1 of 4 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Medplus Health Services Ltd has the lowest comparable Guarded PEG at 1×. Only 1 of 4 companies pass the guard, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

Enterprise Value & Book Value

Medplus Health Services Ltd has the lowest EV/EBITDA among the 4 Pharmacy Distribution companies compared here, at 16.2×. Entero Healthcare Solutions Ltd is next at 22.8×. Sastasundar Ventures Ltd has the lowest P/BV at 1.29×, so level and change sit with different companies. 3 of 4 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Medplus Health Services Ltd leads ev/ebitda at 16.2×; Sastasundar Ventures Ltd leads p/bv at 1.29×.

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/bv signal.

Market action

Entero Healthcare Solutions Ltd has the strongest one-year price move in Pharmacy Distribution at -0.4%. Health X Platform Ltd leads on Mansfield relative strength against NIFTY at +6%. 3 of 4 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-07-17.

What can make this comparison misleading?

This Pharmacy Distribution comparison names 8 specific ways its own evidence can mislead, all listed below. 1 of the 4 companies reports on an older date than the sector's freshest reporters, so its rank is marked stale. 1 draws at least one figure from a second feed with too little overlap to cross-check.

Which companies are included?

All 4 companies in the canonical Pharmacy Distribution membership are listed below, largest market value first — nothing is silently dropped, even where a company reports too little to rank. 1 of these is no longer being priced, so its price and relative strength are frozen at the last traded week shown.

AHEAD means the company is beating the index by 5% or more over three months. LAGGING, FUNDAMENTALS UP means it is 20% or more behind over a year while its trailing twelve-month earnings grew 20% or more. Both rules are fixed and applied the same way in every sector.

How was this comparison built?

This comparison is built from the reported filings of 4 Pharmacy Distribution companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-24. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.

A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from. Every company's standing is listed in the register above.

Pharmacy Distribution company comparison FAQs

These 17 answers restate the Pharmacy Distribution comparison above in question form. Every one is computed from the same 4 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-24. Nothing here is estimated, and none of it is a recommendation.